WHO MONICA Project e-publications, No. 21
February 2000
Editors: Hugh Tunstall-Pedoe1, Diego Vanuzzo2, Michael Hobbs3, Markku Mähönen4, Zygimantas Cepaitis4, Kari Kuulasmaa4, Ulrich Keil5 for the WHO MONICA Project6
1 Cardiovascular Epidemiology Unit, (MONICA Quality Control Centre for Event
Registration), University of Dundee, Ninewells Hospital and Medical School, Dundee,
Scotland, U.K.
2 Centro Malattie Cardiovascolari, A.S.S.4 "Medio Friuli", Udine,
Italy
3 Department of Public Health, University of Western Australia, Perth,
Australia
4 Department of Epidemiology and Health Promotion (MONICA Data Centre),
National Public Health Institute, KTL, Helsinki, Finland
5 Department of Epidemiology and Social Medicine, University of Münster,
Münster, Germany
6 Annex: Sites and key personnel of the WHO MONICA
Project
This is a group of hitherto unpublished MONICA working documents which provide for the critical reader important background information for the paper:
Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mähönen M, Cepaitis Z, Kuulasmaa K, Keil U, for the WHO MONICA Project. Estimation of contribution of changes in coronary care to improving survival, event rates and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000;355:688-700.
The MONICA Centres are funded predominantly by regional and national governments, research councils, and research charities. Coordination is the responsibility of the World Health Organization (WHO), assisted by local fund raising for congresses and workshops. WHO also supports the MONICA Data Centre (MDC) in Helsinki. Not covered by this general description is the ongoing generous support of the MDC by the National Public Health Institute of Finland, and a contribution to WHO from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA for support of the MDC and the Quality Control Centre for Event Registration in Dundee. The completion of the MONICA Project is generously assisted through a Concerted Action Grant from the European Community. Likewise appreciated are grants from ASTRA Hässle AB, Sweden, Hoechst AG, Germany, Hoffmann-La Roche AG, Switzerland, the Institut de Recherches Internationales Servier (IRIS), France, and Merck & Co. Inc., New Jersey, USA, to support data analysis and preparation of publications.